Pluripotent adult stem cells, those derived from the blood, have the ability to divide and generate all cell types and are considered “uncommitted.”
TBI Therapy only uses pluripotent stem cells in efforts to obtain the best results possible! The goal of this treatment is to replace damaged cells and to promote the growth of new blood vessels and tissues in order to help the target organ function at a greater capacity.
The stem cells are extracted using the Tithon Biotech technology. This patented procedure termed PBD-PSC Technology, is founded in discoveries involving a unique population of pluripotent stem cells. These cells were initially isolated from adipose-tissue (fat), but were later found to originate in bone marrow and distributed in peripheral blood as well as other body fluids.
These cells are in abundance in peripheral blood and in reproductive tissue secretions and dissipate in number and function in humans as they age. Tithon Biotech scientists have determined that these cells play a large role in future stem cell based therapeutic applications in both humans and animals.
Stem cells are harvested from the patient’s blood by a simple blood draw typically 6-12 hours before they are infused. During infusion, the patient will lay back on the exam table with their head tilted perpendicular to the ground. After local anesthetic is sprayed into the nose, the cells are dripped up the nose with a special device. The patient will lie there for another 15 minutes while the cells fuse into the brain. After this, the patient is free to get up and continue their daily activities.
To promote optimal regeneration, stem cell infusions are usually paired with several hyperbaric oxygen therapy (HBOT) sessions before and after. Intranasal PRP is also infused the day before stem cells to enhance the regeneration process.